Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure

This publication has 29 references indexed in Scilit:

• Cardiac interstitium in health and disease: The fibrillar collagen network
  Published by Elsevier ,2010
• Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
  Journal of Clinical Investigation, 2000
• A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure
  New England Journal of Medicine, 1998
• Membrane‐Type‐2 Matrix Metalloproteinase Can Initiate the Processing of Progelatinase A and is Regulated by the Tissue Inhibitors of Metalloproteinases
  European Journal of Biochemistry, 1997
• Matrix metalloproteinases
  British Journal of Surgery, 1997
• Circulating Levels of Cytokines and Their Endogenous Modulators in Patients With Mild to Severe Congestive Heart Failure Due to Coronary Artery Disease or Hypertension
  Journal of the American College of Cardiology, 1996
• Circulating concentrations of proinflammatory cytolcines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
  Published by Elsevier ,1996
• Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)
  Journal of the American College of Cardiology, 1996
• Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis
  The American Journal of Cardiology, 1995
• Inadequate collagen tethers in dilated cardiopathy
  American Heart Journal, 1988